
|Articles|March 1, 2007
FDA grants orphan status to two Lux products
The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
















































